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Abstract
Background: Although South Africa has the largest public-sector anti-retroviral treatment (ART) programme in the 
world, anti-retroviral coverage in adults was only 40.2% in 2008. However, longitudinal studies of who is accessing the 
South African public-sector ART programme are scarce. This study therefore had one main research question: who is 
accessing public-sector ART in the Free State Province, South Africa? The study aimed to extend the current literature 
by investigating, in a quantitative manner and using a longitudinal study design, the participants enrolled in the 
public-sector ART programme in the period 2004-2006 in the Free State Province of South Africa.
Methods: Differences in the demographic (age, sex, population group and marital status) socio-economic (education, 
income, neo-material indicators), geographic (travel costs, relocation for ART), and medical characteristics (CD4, viral 
load, time since first diagnosis, treatment status) among 912 patients enrolled in the Free State public-sector ART 
programme between 2004 and 2006 were assessed with one-way analysis of variance, Bonferroni post-hoc analysis, 
and cross tabulations with the chi square test.
Results: The patients accessing treatment tended to be female (71.1%) and unemployed (83.4%). However, although 
relatively poor, those most likely to access ART services were not the most impoverished patients. The proportion of 
female patients increased (P < 0.05) and their socio-economic situation improved between 2004 and 2006 (P < 0.05). 
The increasing mean transport cost (P < 0.05) to visit the facility is worrying, because this cost is an important barrier to 
ART uptake and adherence. Encouragingly, the study results revealed that the interval between the first HIV-positive 
diagnosis and ART initiation decreased steadily over time (P < 0.05). This was also reflected in the increasing baseline 
CD4 cell count at ART initiation (P < 0.05).
Conclusions: Our analysis showed significant changes in the demographic, socio-economic, geographic, and medical 
characteristics of the patients during the first three years of the programme. Knowledge of the characteristics of these 
patients can assist policy makers in developing measures to retain them in care. The information reported here can also 
be usefully applied to target patient groups that are currently not reached in the implementation of the ART 
programme.
Background
In November 2003, the South African Cabinet
announced the Operational Plan for Comprehensive HIV
and AIDS Care, Management and Treatment for South
Africa [1]. This policy document set out a coherent, com-
prehensive strategy to deal with human immunodefi-
ciency virus (HIV) and acquired immunodeficiency
syndrome (AIDS) and explicitly included the use of anti-
retroviral medicines for the treatment of HIV and AIDS
(anti-retroviral treatment or ART) for HIV/AIDS patients
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Page 2 of 13with CD4 count ≤ 200 cells/μl or World Health Organiza-
tion (WHO) stage IV disease [2]. In 2007, the HIV &
AIDS and STI National Strategic Plan (NSP) 2007-2011
re-affirmed this emphasis on treatment by adopting as its
two primary aims to reduce new HIV infections by 50%,
particularly through the prevention of mother-to-child
transmission (PMTCT), and to reduce the impact of the
epidemic by extending access to appropriate treatment,
care, and support to 80% of people diagnosed with HIV
[3].
Preliminary research results showed that ART provided
by the South African government health services is as
effective as that provided in high-income countries [4].
The magnitude of the improvements in health and quality
of life attributable to ART is similar to the estimates for
non-governmental organisations (NGOs) and research-
supported ART services in developing countries and for
routine treatments in Europe and the United States [4-
10]. Studies of the ART programme outcomes have also
indicated that South Africa ranks among the top African
countries in patient survival and retention rates [11,12].
Finally, despite severe human resource shortages, health
personnel provide high-quality care, which results in high
levels of patient satisfaction with ART-related services
[13-15].
These favourable treatment outcomes should not
encourage complacency. Despite having the largest pub-
lic-sector ART programme in the world, the South Afri-
can ART roll-out is hampered by limited financial and
human resources [16-18]. The health-care system is fac-
ing a crisis and the government is falling behind in its
efforts to meet the NSP targets, including the treatment
of 80% of people who require ART by 2011 [3]. By the
middle of 2008, 568,000 HIV-infected patients were
receiving ART in South Africa, with the public health
sector accounting for 79% of this total. Based on the cur-
rent Department of Health criteria for defining anti-ret-
roviral eligibility (CD4+ count < 200/μL or World Health
Organization [WHO] stage IV), anti-retroviral coverage
in adults was only 40.2% in 2008 [19]. Moreover, coverage
varied significantly between the provinces, with the Free
State, the subject of this study, ranking last (25.8%)[19].
This creates a risk of ART facilities becoming "islands of
excellence in a sea of under provision" [20-22]. ART facil-
ities have a positive impact on the lives of patients
enrolled in the programme, but after five years of treat-
ment roll-out, their effects are still inequitable, serving
less than half of the people who currently require ART in
South Africa [23]. The large gap between the number of
people eligible for ART and the number of people actu-
ally accessing care creates a nationwide problem, with
long waiting lists. Recent studies by Jacobs et al. (2008)
and Rosen et al. (2005) have shown that the large patient
numbers and resource constraints mean that ART in
South Africa will be rationed for many years to come
[24,25].
Bennet and Chanfreau (2005) have stressed that it is
crucial to monitor who has access to treatment when
anti-retroviral programmes are implemented in regions
in which they are most needed [26]. Knowing the charac-
teristics of the enrolled patients can potentially facilitate
the successful implementation of the NSP in two ways.
First, knowledge of the characteristics of the enrolled
patients can assist policy makers in developing measures
to retain these patients in care, a necessary condition for
every ART programme. Second, information about these
patients' characteristics can identify explicit and implicit
rationing systems when the over- and under-represented
groups of patients are evaluated [27]. In this respect,
Rosen et al. (2005) identified different types of rationing
systems, using socio-economic, geographic, and medical
criteria [25]. The information produced could then be
usefully applied by policy makers to target patient groups
that are not reached in the implementation of the current
ART programme.
Longitudinal studies of who is actually accessing the
South African public-sector ART programme are scarce
[28]. This study has therefore one main research ques-
tion: who is accessing public-sector ART in the Free State
Province of South Africa? The study aimed to extend the
current literature by investigating, in a quantitative man-
ner and using a longitudinal study design, the partici-
pants enrolled in the public-sector ART programme in
the period 2004-2006 in the Free State Province of South
Africa. Interview data for 912 ART patients were used to
assess the differences in the demographic (age, sex, popu-
lation group, marital status), socio-economic (education,
income, neo-material indicators), geographic (travel
costs, relocation to obtain ART), and medical (CD4+
count, viral load, time since first diagnosis, treatment sta-
tus) characteristics between patients enrolled at various
points in time. Furthermore, by identifying differences
between the patients who enrolled at different time
points, the study assessed whether certain patient groups
were benefitting disproportionately from the public-sec-
tor ART programme, so that the distribution of public
health benefits was uneven across the population. This
information could be usefully applied in the development
of policy measures that target groups of eligible patients
who are not currently accessing ART.
Methods
Setting
This study is part of a longitudinal study (entitled Public
sector anti-retroviral treatment: documenting, monitor-
ing, evaluating, and facilitating implementation of the
national treatment plan in the Free State Province, South
Africa) of patients enrolled in the public-sector ART pro-
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Page 3 of 13gramme in the Free State Province of South Africa. This
research was approved by the Ethics Committee of the
Faculty of Humanities, University of the Free State, and
authorised by the provincial Department of Health.
Study population
The larger longitudinal study had two distinct objectives.
Firstly, the patient survey needed to generate data that
could be employed to investigate the experience over
time of a representative cohort of patients that qualify for
ART at the start of the public-sector ART programme in
the Free State (i.e. CD4 < 200 cells/μL and/or WHO stage
IV AIDS). It was estimated, based on the ASSA2000
model, that a total of 28 290 HIV-positive persons would
develop WHO stage IV AIDS defining illness annually in
the province [29]. In order to detect a 5% difference in
this population at the 95% confidence level, one needed
to observe a sample of 379 patients. However, because
estimates of the number of patients with WHO stage IV
AIDS defining illness were not available at the district
level, it was decided not to sample patients from each dis-
trict in proportion to population size and HIV-prevalence
in the particular district, but rather to sample an equal
number of patients in each district. In light of available
resources, the estimated sample size of 379 was inflated
to 400, with 80 patients to be interviewed per district. In
cases where the list included fewer than 80 patients, as in
Xhariep District, a census of all treatment and non-treat-
ment cases was conducted. This resulted in a total sample
size of 371 patients interviewed in the first months after
the start of the ART programme. The Free State Depart-
ment of Health implemented ART in a phased or stag-
gered manner: the first district (Lejweleputswa) started in
February 2004, the last district (Fezile Dabi) only started
in December 2004. The current study only employs this
baseline data. However this cohort of 371 patients was
followed over the entire three-year period.
Secondly, the patient survey also needed to generate
data that could be employed to generalise about the expe-
riences of patients that were in the ART programme in
each of the five districts in the Free State Province as well
as in the province as a whole over a three-year period
(2004-2006). The objective here was to provide a repre-
sentative picture of patient experiences over the course of
the rollout of ART in the province and each of its five dis-
tricts, so as to evaluate the treatment programme in
terms of select outcomes. However, data from the inter-
views with cohort patients could not be used to draw
conclusions about the treatment programme at later
stages. For this reason, we sampled additional treatment
cases from a list of new patients, i.e. all patients that have
received treatment since the first sample was drawn,
when conducting the four follow-up rounds of interviews
with the cohort. Using six-monthly intervals, we sampled
new interviewees randomly from the population of
patients that had commenced treatment since the previ-
ous round of interviews. In the interest of affordability,
the maximum number of new treatment cases to be sam-
pled in each district in any one period equalled 40, which
we believe would still allow us to generalise to the district
and provincial ART programme levels in terms of the
ART programme. This resulted in an additional 541
patients (cross-sections) being interviewed.
The current study employs both datasets (baseline
cohort data and cross-sectional data) to provide an over-
view of the characteristics of the patients enrolling into
the Free State public-sector ART programme during its
first three years. For budgetary reasons, the 371 patients
sampled in the above manner represented both the base-
line of the cohort study (see 1st objective) as well as the
sample for the first representative cross-section of the
ART programme (see 2nd objective). The total sample size
was thus 912 patients (371 cohort patients and 541 cross-
sections) who started treatment between 2004 and 2006.
These were all adult patients who were medically certi-
fied as ready for ART (CD4 < 200 cells/μL and/or WHO
stage IV AIDS defining illness). Written, informed con-
sent was obtained from all study participants by the nurs-
ing personnel at the respective clinics, as well as by the
enumerators. In addition to the interview data, clinical
data on the cohort patients (N = 371) were collected
directly from the patient files, only after the written con-
sent of all the patients had been obtained and with the
authorisation of the provincial Department of Health.
Data collection and study variables
To assess the demographic characteristics of the respon-
dents, data were collected on sex, age, population group
(black, coloured, white or Asian), and marital status (sin-
gle/not living together, living together and unmarried, or
living together and married). Our sample did not include
patients from Asian origin, which is not surprising as
recent estimates indicate that the Asian population only
accounts for 0.1% of the Free State population [30].
Educational level and personal monthly income were
added to the model as classical indicators of the patient's
socio-economic position. To measure educational level,
five educational categories were established based on the
patient responses: no education, primary school, some
secondary education, grade 12, and tertiary education.
Employment status (employed, unemployed) was mea-
sured dichotomously. Because unemployment is high in
South Africa (and subject to temporal changes), changes
in the labour market participation rate (defined here as
the percentage of the population of working age currently
employed or actively seeking work) were assessed [31].
Personal monthly income (excluding social welfare
grants) was included in the analysis, as a continuous vari-
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participants, they were asked whether they received a
social welfare grant (in particular, a disability grant). Four
neo-material measures were included because previous
analyses had shown them to be important determinants
of socio-economic position [32-36]. The type of housing
that the respondents occupied was categorised dichoto-
mously into informal or traditional dwellings versus for-
mal dwellings. A second variable measuring socio-
economic status referred to the size of the dwelling: a
continuous variable measured the number of rooms the
household actively used. However, the absolute size of the
dwelling is often an inaccurate measure of the actual
space per occupant because the sizes of households can
vary greatly. We therefore also considered the ratio of the
dwelling size to the household size (i.e., the average num-
ber of rooms per person). Finally, the type of toilet facility
(flush toilet, pit latrine, bucket latrine, chemical toilet,
none) and its location (inside dwelling, on-site/in yard,
off-site/outside yard) were used as neo-material indica-
tors of the socio-economic positions of the respondents
[32].
An obvious way of limiting access to treatment is to
offer ART only to patients residing in specified geo-
graphic catchment areas [37-39]. The South African
Department of Health did not use such an explicit geo-
graphic rationing strategy. However, the ART programme
was to be phased in over a five-year period with the aim
of achieving universal coverage of new AIDS cases by the
end of the 2008/09 financial year. In the Free State, one
service point in each of the five districts was envisaged
within the first two years, with a steady expansion there-
after to all appropriate facilities (20 local municipal areas
in total) [40]. The obvious rationing system here is that
the majority of those patients not living within these few
initial catchment areas would be excluded unless they
were willing to relocate [41]. To assess these potential
geographic rationing systems, we would ideally measure
the Euclidian (or straight-line) distance between each
patient's home and the specific assessment site where the
patient accessed ART [29]. However, in the absence of
such data, we used two proxy measures to evaluate the
potential geographic differences among patients enrolling
at different points in time. First, we investigated the pro-
portion of patients who had to move, i.e., from one resi-
dence to another to access public-sector ART. Second,
research in South Africa and Malawi identified transport
costs as a barrier to the initial uptake of ART, as well as to
patient adherence [42,43]. Therefore, it was useful to
know how the cost to the patient, of transport to the ART
facility, changed over time. In practice, the cost of a one-
way trip to the ART facility was used to measure changes
in this potential barrier to the uptake of and adherence to
ART.
The medical selection criteria required that the patients
were symptomatic (WHO clinical stage IV AIDS defining
illness) and/or had a CD4 lymphocyte count below 200
cells/μL blood. A physician subsequently assessed the
patient to confirm that the patient fulfilled the criteria for
treatment and to exclude any reason for delaying treat-
ment (e.g., untreated tuberculosis). The patients were
then referred back to the assessment site for drug readi-
ness training, a programme lasting three weeks [44].
There was no prioritisation for ART. The patients were
randomly chosen for ART from those eligible for the pro-
gramme and were not given preference based on CD4
count, viral load, or the time waiting for ART [23,45].
However, the demand for ART greatly surpasses its sup-
ply, so a study of the medical characteristics of those eligi-
ble patients actually accessing treatment is very useful
[46]. CD4 cell counts and plasma HIV viral RNA levels,
measured immediately before the commencement of
ART, were used as the baseline measures of CD4 cells and
viral load, respectively. These clinical data were only
gathered from patients sampled for the first round of
interviews (N = 371), which included only those patients
who started treatment in 2004 and 2005. In the absence
of clinical data from the patient files on all the study par-
ticipants, two additional measures were used to assess the
medical status of the patients enrolled in the public-sec-
tor ART programme: the time since their first diagnosis
and their treatment status. Ample studies have shown
that the delayed initiation of ART significantly reduces
the chance of treatment success [47-49]. For this reason,
the time since the first HIV-positive diagnosis was
included in this study to assess the HIV-positive patient's
trajectory towards ART. "Treatment status" distinguished
treatment-naïve patients from patients who had previ-
ously received ART (from disease management pro-
grammes, workplace treatment programmes, or NGO
programmes) before enrolling in the public programme.
Data analysis
The differences in demographic (age, sex, population
group and marital status), socio-economic (education,
income, living circumstances), geographic (travel costs,
relocation for ART), and medical (CD4, viral load, time
since the first diagnosis, treatment status) of the various
patient groups' (2004-2006) characteristics were assessed
using one-way analysis of variance (ANOVA). An addi-
tional Bonferroni post-hoc analysis was used to assess the
differences between the patient groups who enrolled at
different times. Differences between the patient groups in
nominal and ordinal variables were examined using
cross-tabulations and were tested for statistical signifi-
cance with a χ2 test [50]. All analyses were performed
with the statistical software package SPSS version 15.0.
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Sample description
The mean age of this sample of people living with AIDS
was 37.4 years (Table 1). Of the 912 ART patients
included in the study, 71.1% were women (Table 2).
Descriptive statistics showed an over-representation of
the black population group, whereas only a very small
proportion of the participants were coloured or white.
Our sample did not include patients from Asian origin,
which is not surprising as recent estimates indicate that
the Asian population only accounts for 0.1% of the Free
State population [30]. Univariate analysis showed that
18.6% of respondents were married, whereas 9.7% of
respondents lived together with a partner to whom they
were not married. However, the majority of respondents
did not cohabit with a partner (single, divorced, widowed,
living apart). Education levels were relatively low, with
only 17.1% of the sample (14.6% + 2.5%) having com-
pleted secondary education and only 2.5% having some
form of tertiary education. The vast majority of respon-
dents had only completed primary education or had
started but did not finish secondary education, whereas
4.4% had no formal education at all. Overall, only 16.6%
of respondents had worked for pay, profit, or family gain
in the seven days preceding the interview. The mean per-
sonal monthly income of these employed respondents
was ZAR1657.8 (SD = ZAR1411.9). The labour market
participation rate indicated that 43.1% of respondents
had either worked or taken active steps to find work in
the four weeks before the interview. More than half the
respondents received a social welfare grant (particularly a
disability grant), which amounted to ZAR740, ZAR780,
or ZAR820 per month, depending on when the interview
was conducted. The large majority of respondents lived
in a formal dwelling (76.7%), meaning that only 23.3% of
respondents lived in an informal or traditional dwelling.
The mean number of rooms used by the household was
3.8. The assessment of sanitary facilities showed that
70.4% of respondents had access to a flush toilet and
almost all respondents (96.3%) had access to a toilet in
either their house or yard. The mean cost incurred by a
one-way trip to the facility was ZAR8.4, with 14.5% of
patients incurring no cost to get to the facility. Only 1.1%
of respondents had relocated to access public-sector
ART. The respondents had been diagnosed with HIV
from three days to 15 years before their entry into the
programme (mean = 21.4 months). The mean CD4 cell
count at baseline (ART initiation) was 120.8 cells/μL. At
the start of treatment, the mean baseline viral load was
302,490 copies/mL. Finally, 6.6% of patients had previ-
ously received ART before the Free State public pro-
gramme began.
Table 1: One-way ANOVA of the temporal differences in the demographic, socio-economic, geographic, and medical 
characteristics of patients enrolled in the Free State public-sector anti-retroviral treatment programme between 2004 and 
2006 (N = 912)
2004 2005 2006 Total F scores
(n = 223) (n = 485) (n = 204) (df)
Age * (years, mean [SD]) 37.9 (9.0) 37.7 (8.3) 36.1 (7.7) 37.4 (8.4) 3.192 (2, 844)
Personal monthly incomea (ZAR, mean [SD]) 1774.2 (1439.0) 1737.6 (1486.8) 1007.9 
(760.3)
1657.8 (1411.9) 1.727 (2, 108)
Dwelling size, number of roomsa (mean [SD]) 3.9 (1.9) 3.7 (1.6) 4.0 (1.7) 3.8 (1.7) 0.044 (2, 844)
Transport cost * (ZAR, mean) 6.8 (9.1) 8.5 (12.4) 10.1 (14.7) 8.4 (12.2) 3.259 (2, 589)
CD4 cell count at ART initiation * 109.3 (73.7) 138.9 (73.6) 120.8 (74.8) 4.229 (1, 109)







Days since first HIV-positive diagnosis * (mean 
[SD])
772.7 (971.7) 625.4 (747.8) 545.9 (748.3) 642.9 (806.9) 3.756 (2, 820)
* p < .05
a not significant (P ≥ 0.05)
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Table 2: χ2 test of the temporal differences in the demographic, socio-economic, geographic, and medical characteristics of 
patients enrolled in the Free State public-sector anti-retroviral treatment programme between 2004 and 2006 (N = 912)
2004 2005 2006 Total Significance
(n = 223) (n = 485) (n = 204)
Sex Male 35.8 27.6 24.6 28.9 < 0.05
Female 64.2 72.4 75.4 71.1
Population group Black 94.7 94.7 91.1 94.0 < 0.05
Coloured 4.1 5.3 8.9 5.8
White 1,2 0.0 0.0 0.2
Marital status Married, living together 21.9 19.0 14.1 18.6 n.s.
Unmarried, living together 7.3 10.3 10.5 9.7
No cohabitation with partner 70.8 70.7 75.4 71.7
Education No formal education 3.1 5.2 3.5 4.4 < 0.05
Primary education 23.3 33.8 33.3 31.3
Some secondary education 52.3 45.4 46.8 47.2
Grade 12 15.5 14.0 15.2 14.6
Tertiary education 5.7 1.6 1.2 2.5
Work for pay No 80.8 85.4 80.7 83.4 n.s.
Yes 19.2 14.6 19.3 16.6
Labour market participation No 63.5 57.9 46.1 56.9 < 0.005
Yes 36.5 42.1 53.9 43.1
Social welfare grant No 47.7 43.2 46.2 44.8 n.s.
Yes 52.3 56.8 53.8 55.2
Dwelling type Formal 77.7 74.2 82.5 76.7 n.s.
Informal/traditional 22.3 25.8 17.5 23.3
Toilet type Flush toilet 60.1 68.7 87.1 70.4 < 0.001
Pit latrine 30.1 20.8 11.2 21.0
Bucket latrine 8.8 9.1 1.8 7.5
Chemical toilet 0.5 1.0 0.0 0.7
None 0.5 0.4 0.0 0.4
Toilet site Inside dwelling 28 31.5 49.4 34.3 < 0.001
On-site/in yard 69.4 63.5 49.4 62.0
Off-site/outside yard 2.6 4.9 1.2 3.7
Moved for ART No 98.4 99.0 99.4 98.9 n.s.
Yes 1.6 1.0 0.6 1.1
Previous ART No 88.6 94.0 97.0 93.4 < 0.005
Yes 11.4 6.0 3.0 6.6
n.s. not significant (P ≥ 0.05)
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patient groups
We used cross-tabulation with the χ2 test to examine the
association between the patient's sex and the year in
which he/she enrolled in the Free State public-sector
ART programme. The analysis showed a significant asso-
ciation between the patient's sex and the year of enrol-
ment. In 2004, 64.2% of the new patients were female, and
this proportion increased steadily to 75.4% in 2006. One-
way ANOVA was used to assess the association between
patient age and the year of enrolment. When the results
of the ANOVA were statistically significant (P < 0.05),
post-hoc Bonferroni multiple comparisons were made to
determine where statistically significant differences
between the group means existed (Table 3). The analysis
revealed significant differences in patient age across
enrolment years. Further post-hoc analyses revealed that
the ages of the patient groups were only significantly dif-
ferent between the first two and the third year of the ART
programme, indicating that the mean age of the patients
who started ART in 2004 was similar to that of the
patients who started ART during the following year,
whereas the patients who started in 2006 were slightly,
but significantly, younger than those who started treat-
ment during the previous two years. A bivariate analysis
using the χ2 test revealed no significant association
between the patient's marital status and the year of enrol-
ment. However, population group (black, coloured, or
white) was significantly associated with the year of enrol-
ment. The study findings show a steady increase in the
proportion of coloured patients enrolling in the pro-
gramme, while the proportion of black patients decreased
slightly. However, the latter remained the dominant pop-
ulation group in the programme.
Differences in socio-economic status across patient groups
First, the analysis revealed significant differences in the
patients' educational levels across the first three years of
ART enrolment (P < 0.05). The proportion of patients
who had not undertaken at least some secondary educa-
tion rose from 26.4% in 2004 to 39.0% in 2005. In 2006, no
further increase was observed. A bivariate analysis
showed no significant association between employment
status and the year of enrolment in the ART programme.
If we focus on the employed patients, one-way ANOVA
revealed no significant differences between the patients'
personal monthly incomes across the first three years of
ART enrolment. A bivariate analysis suggested that the
labour market participation rate among patients enrolled
in the Free State public ART programme steadily
increased during the first three years of the programme.
Initially, only 36.5% of patients were either employed or
actively looking for employment; this proportion rose to
42.1% in 2005 and to 53.9% in 2006. Finally, we investi-
gated those patients who were unable to work: cross-tab-
ulation with a χ2 test indicated that the proportion of
enrolled patients who received a disability grant did not
change significantly over time.
Second, this study included four neo-material indica-
tors of socio-economic position to assess any potential
differences between the patients enrolled at different
stages of the ART programme. A bivariate analysis using
a χ2 test showed that there was no significant association
between dwelling type and the year of enrolment.
Throughout the study period, approximately four of
every five respondents lived in a formal dwelling, and the
remainder lived in an informal or traditional dwelling.
One-way ANOVA revealed no between-group differ-
ences with regard to the size of the dwelling, making
post-hoc Bonferroni multiple comparisons redundant.
The study results showed that the size of the dwelling
remained stable between 2004 and 2006. However, the
absolute size of the dwelling is often an inaccurate mea-
sure of the actual space per occupant because the sizes of
households can vary greatly. When we considered the
ratio of the dwelling size to the household size (i.e., the
average number of rooms per person), one-way ANOVA
again revealed no significant between-group differences,
indicating that the ratio of dwelling to household size did
not differ significantly across the initial years of the public
anti-retroviral programme. The final two neo-material
indicators of the patients' socio-economic status assessed
the household's sanitary facilities. The study results
showed a steady and significant increase in the propor-
tion of patients with access to a flush toilet. Conse-
quently, the proportion of households living under poor
sanitary conditions decreased over time. A similar trend
was apparent when the locations of these toilet facilities
were assessed: in 2004, less than one third of the patients
enrolled in the ART programme had a toilet inside their
dwelling; in 2006, this proportion had increased to 49.4%.
Geographic differences across patient groups
We attempted to assess whether the Free State's phased
approach to ART implementation had an unintended
impact on who enrolled in the public-sector ART pro-
gramme. The initially small number of service points in
each of the five districts could have favoured patients liv-
ing within the immediate catchment areas of the facili-
ties. One-way ANOVA was used to assess the association
between the patient's transport costs and the year of
enrolment, and showed significant temporal changes in
the mean cost of a one-way trip to the facility. The post-
hoc Bonferroni test indicated that the mean cost of a one-
way trip to the ART facility was significantly lower in
2004 than in the two subsequent years (Table 3). There
was no significant difference in the travel costs in 2005
and 2006. However, it is possible that those patients not
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to live near the ART facility. Consequently, we also
assessed the association between year of enrolment and
whether the patient had relocated to access public-sector
ART. A bivariate analysis revealed no significant associa-
tion: overall, very few patients had ever relocated to
access ART and this percentage remained stable through-
out the study period.
Medical differences across patient groups
Due to the fact that the number of patients medically eli-
gible for ART greatly exceeds the number of patients
actually accessing the treatment, in this study, we wanted
to investigate the trajectory that patients complete
between their first HIV-positive diagnosis and their
enrolment in the public-sector ART programme. First,
the time since the first HIV-positive diagnosis was
assessed. One-way ANOVA was used to assess the asso-
ciation between the time since their first diagnosis and
the year of enrolment. The analysis revealed that the
delay between the first HIV-positive diagnosis and the
start of public-sector ART differed significantly across
the first three years of the ART programme. To deter-
mine exactly where these differences occurred, we exam-
ined the results of Bonferroni multiple comparisons
(Table 3). The post-hoc tests revealed that the time since
the first HIV-positive diagnosis steadily and significantly
declined throughout the entire study period. In 2004, a
patient knew that he/she was HIV positive for, on aver-
age, 772.7 days (SD = 971.7) before starting ART; in 2005,
the mean period was 625.4 days (SD = 747.8; P < 0.05);
and in 2006, this period had decreased to 545.9 days (SD
= 748.2; P < 0.05). Second, we analysed the patients' tra-
jectories towards public-sector ART by investigating
whether the patients had received ART from an alterna-
tive provider (disease management programmes, work-
place treatment programmes, or NGO programmes)
before enrolling in the public-sector ART programme. A
bivariate analysis showed a significant association
between treatment status (treatment naive or not) and
year of enrolment. The patients who enrolled in 2004
(11.4%) were almost four times more likely to have previ-
ously received ART from an alternative provider than
were patients who commenced public-sector ART in
2006 (3.0%), showing a clear trend in the treatment status
of enrolling patients over time. Third, one-way ANOVA
revealed a significant difference in the CD4 cell counts at
the beginning of ART of patients who started treatment
in 2004 and those who started in 2005. The mean number
of CD4 cells/μL blood at the start of ART increased from
109.3 (SD = 73.7) in 2004 to 138.9 (SD = 73.6) in 2005.
Finally, our analysis showed no significant association
between the baseline viral load and the year of enrolment.
Discussion
During the introductory years of the South African pub-
lic-sector ART programme (2004-2006), anti-retroviral
coverage rose from 4.9% in 2004 to 19.1% in 2006 (and to
40.2% in 2008). The preliminary patient outcomes of the
programme were positive [4,49], indicating that South
Africa ranks among the top African countries for patient
survival and retention rates, approaching those reported
in industrialised countries [11,12]. Despite significant
progress in the provision of ART in South Africa, human
and financial resource shortages create a large gap
between the supply and demand for ART. Currently, only
four of every 10 South Africans requiring treatment are
actually receiving it. The situation is most acute in the
Free State, where ART coverage is only 25.8% [19].
Against the backdrop of this gap between supply and
demand, Stewart et al. (2006) raised concerns that the
provision of ART will create and/or exaggerate inequities
in service provision [51]. Therefore, it is crucial to moni-
tor who gains access to these life-saving drugs when anti-
retroviral programmes are implemented in regions with
high HIV prevalence and limited resources [26]. Using
Rosen's typology of implicit rationing systems [25], we
measured the demographic, socio-economic, geographic,
and medical characteristics of the patients enrolling in
the Free State public-sector ART programme between
2004 and 2006.
Table 3: Pairwise comparisons: Bonferroni tests for differences in mean age, transport cost, and days since the first HIV-
positive diagnosis over time (N = 912)
Multiple comparisons Age Transport cost Days since first diagnosis
Difference Difference Difference
2004-2005 0.138a -1.758* 147.300*
2004-2006 1.900* -3.399* 226.828**
2005-2006 1.762* -1.641a 79.497*
* p < .05, ** p < .01
a not significant (P ≥ 0.05)
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four domains. Demographically, the results showed a sig-
nificant increase over time in the proportion of females
entering the programme, resulting in an under-represen-
tation of male patients in the public-sector ART pro-
gramme. A similar trend was found in an Ethiopian study
by Kloos et al. (2007) and a Thai study by Le Cœur et al.
[52,53]. Because HIV infection rates are higher among
women, it is to be expected that more women than men
are receiving ART. However, our findings show that the
proportion of women undergoing treatment was signifi-
cantly higher than would be expected given the demo-
graphic trends [54]. In 2006, three of every four (75.6%)
patients enrolling in the ART programme were female,
whereas the expected percentage based on national
reports was only 56% [55]. A WHO report on the global
access to anti-retroviral therapy [55] speculated that the
relative over-representation of women in ART pro-
grammes could be because women are better integrated
into community networks, and thus have better health-
care information and are better able to access public
health facilities than are men, especially where these
women access PMTCT programmes. Closely related,
recent studies suggest that antenatal clinics are often the
first point of entry into HIV/AIDS prevention, care and
treatment [56,57]. Nattrass (2008) hypothesised that
South African men with AIDS-related illnesses are less
likely to access ART than their female counterparts
because masculine norms encourage them to deny weak-
ness and to avoid seeking treatment for any ailment for as
long as possible [54]. Another possible explanation for
this difference is the fact that the South African employ-
ment rate is substantially higher among males (50.5%)
than among females (34.0%) [58]. Because each visit to
the clinic can be assumed to require a full day off work as
a result of the protracted waiting times at the facilities
[14,59], the cost of losing a day of work for health care
may still be too high [60,61], resulting in the reported
under-representation of employed (predominantly male)
patients. However, further research is required to fully
disentangle the complex relationship between sex and
public-sector ART access. Our study also revealed signifi-
cant but very small differences in the ages of the patients
enrolling at different time points, with more recent
patients being slightly younger. However, this very small
reduction in the mean age of treatment initiation does
not warrant any policy measures. Finally, the proportion
of coloured patients accessing public-sector ART
increased over time, although black patients still consti-
tuted the largest population group in the programme.
These findings confirm those of previous studies per-
formed by Natrass (2006), Tladi (2006), and Hudspeth
(2004) [62-64].
As we would expect in a public-sector health-care pro-
gramme, the ART patients can be described as relatively
poor in certain respects: only one of every five respon-
dents was employed and this percentage remained stable
over time. Analysis of the association between socio-eco-
nomic status and access to public-sector ART revealed a
growing trend in labour-market participation among
ART patients over time. In other words, patients enroll-
ing in 2006 were more likely to be either employed or
looking for work than were patients enrolling during the
first two years of the programme. However, our analysis
of employment trends displayed no significant direction,
indicating that the proportion of employed patients
remained low. As suggested above, one potential explana-
tion is that employed (predominantly male) patients are
under-represented in the ART population because of the
protracted waiting times at the facilities, warranting fur-
ther research on this topic. Our study found no signifi-
cant association between the remaining classical
indicators of socio-economic status (monthly income,
disability grant, employment status) and entry into the
ART programme. The analysis of neo-material indices of
health inequality showed a clear trend in the housing
conditions of the enrolled patients over time: the toilet
facilities (both their place and type) improved signifi-
cantly during the three-year study period. Previous stud-
ies by Anderson et al. (2006) and Booysen et al. (2006 and
2007) have already shown that that the initial group of
ART patients was not the poorest of the poor [29,65,66].
Our finding that the majority of patients had access to a
flush toilet, either in their dwelling or their yard, con-
firmed these conclusions and also suggests that these
inequities worsened over time.
In previous studies, the distance from home to the
health facility was often cited as one of the most impor-
tant barriers to the initial uptake of ART and to patient
adherence [42,67]. Our study showed that the mean
transport cost of a one-way trip to the facility increased
significantly (from ZAR 6.8 to ZAR 10.1) over the first
three years of the Free State public-sector ART pro-
gramme. A potential explanation would be that the initial
(most urgent) treatment patients moved to live close to
the ART facility, but the study results showed no signifi-
cant association between the year of enrolment and
whether the patient had relocated to access ART. It is also
noteworthy that the intention of the Free State was that
the programme implementation would occur in a phased
or staggered manner, and as resources and experience
became available [44]. During phase I of the ART roll-out
in the province (May-December 2004), four treatment
sites, 13 assessment sites, and three combined sites were
established. In phase II (2005/2006), a further three treat-
ment, eight assessment, and seven combined sites were
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more ART facilities, it would be logical to see an accom-
panying gradual reduction in the mean distance (and
transport cost) to the nearest ART facility. The evidence
suggesting that cost is an important barrier to ART
uptake and adherence indicates that further research is
required to investigate this worrying trend.
Finally, our study results reveal that eligible patients
(CD4 < 200 cells/μL and/or WHO stage IV AIDS) are
gradually enrolling at a slightly earlier stage of HIV infec-
tion. The interval between the first HIV-positive diagno-
sis and ART initiation is steadily decreasing over time.
This is also reflected in the increasing baseline CD4 cell
counts at ART initiation. This trend towards earlier
enrolment and initiation of treatment is potentially
important because many studies have indicated that
delayed ART initiation (low baseline CD4 and high viral
load) significantly reduces the chance of ART success
[21,69]. These results for the initial years of public-sector
ART are also consistent with the recommendations for
ART scale-up made by Walensky et al. (2008) [23]. Their
simulation model showed that the prioritisation of the
sickest patients (i.e., those with the lowest CD4 counts)
would lead to significantly fewer deaths compared with
the number of deaths in non-prioritised scenarios. How-
ever, this positive trend does not justify complacency.
The overall low baseline CD4 cell count among the ART
patients (120.8 cells/μL) in our sample is similar to that
observed in previous studies in South Africa [35,70,71].
These results once again show that increasing the recom-
mended CD4 count at which patients begin ART from
200 to 350 cells/μL blood, as stated in the new WHO pro-
tocol for ART, will require extensive efforts to reach these
currently untreated patients [72]. This will prove to be a
difficult task in the context of crippling human and finan-
cial resource shortages for health services [17]. Finally,
the study showed a clear trend of more ART-naïve
patients being enrolled in the public-sector ART pro-
gramme over time, whereas earlier patients had received
ART from other sources before transitioning into the
programme. The introduction of free public-sector ART
clearly attracted patients from alternative ART pro-
grammes, while gradually eligible patients increasingly
directly enrolled into the public-sector programme.
The strengths of this study include its longitudinal
character and the availability of information on an under-
studied population. To the best of our knowledge, this is
one of the first studies to assess, in a quantitative manner,
the demographic, socio-economic, geographic, and med-
ical characteristics of a representative sample of HIV-
infected patients enrolling in South Africa's public-sector
ART programme [52]. However, there are some limita-
tions to our study. First, our data set only includes eligible
patients enrolling before 2007. Further research is
required to monitor the more recent trends in patient
characteristics. Second, the study only included patients
eligible for ART who actually presented for and accessed
treatment. As stated before, the Free State's anti-retrovi-
ral coverage was only 25.8% in 2008 [19]. Consequently,
further research is required to investigate the characteris-
tics of the most vulnerable HIV/AIDS patients, those eli-
gible for treatment but who do not access it. Third, a
comparatively small number of variables, based on the
available survey items, was used to measure the demo-
graphic and medical characteristics of the patients,
potentially restricting the reliability and validity of these
measures. Finally, the reported associations between the
patient characteristics and their entry into the ART pro-
gramme may not be generalisable to alternative settings.
We can only ascribe the findings to patients enrolled in a
public-sector ART programme and, more specifically, to
patients enrolled in South Africa's public ART pro-
gramme, as implemented in the Free State Province.
Conclusions
Our analysis of 912 HIV/AIDS patients starting ART in
the Free State public-sector ART programme showed sig-
nificant changes in the demographic, socio-economic,
geographic, and medical characteristics of the patients
during the first three years of the programme. The
patients accessing treatment tended to be female and
unemployed. Although relatively poor, those who were
most likely to access ART services were not the most
impoverished social group. The proportion of female cli-
ents increased and their socio-economic situation
improved between 2004 and 2006. The increasing mean
transport cost for a visit to the facility is worrying,
because this cost is an important barrier to ART uptake
and adherence. Eligible patients are accessing ART at an
increasingly earlier stage of HIV infection, which is a pos-
itive trend because delayed ART initiation significantly
reduces the chance of ART success. Although our knowl-
edge of the characteristics of those patients actually
accessing public-sector ART in a resource-poor setting is
still in its infancy, this analysis has both practical and the-
oretical implications.
Theoretically, this study contributes to our understand-
ing of the impact of a large-scale public ART programme
on the population of patients eligible for treatment. The
study results show that as long as the demand for ART
exceeds the supply, implicit rationing of anti-retroviral
therapy for HIV/AIDS is inevitable. Despite national pol-
icies that recognise the importance of equitable access to
ART, the early evidence in the Free State is that these pro-
cesses can have unwanted inequitable effects. The
research community should devote more attention to the
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the context of large patient numbers and limited human
and financial resources.
In practical terms, the study results show the impor-
tance of monitoring the population with access to ART
programmes in the regions where they are most needed
[26]. A knowledge of the characteristics of the public-sec-
tor ART clients can potentially facilitate the successful
implementation of the NSP. To reach the NSP's ambitious
goal of providing treatment to 80% of HIV/AIDS patients
who require it by 2011 [3], policy makers need data from
research studies about the eligible patients who are
accessing ART and those who are not, to maximise the
policy outcomes in a context of limited resources. A
knowledge of the characteristics of the enrolled patients
can assist policy makers in developing measures to retain
these patients in care, a conditio sine qua non for every
ART programme. Moreover, the information provided
can be used to identify and target patient groups that are
not currently benefitting from the implementation of the
ART programme.
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